[1] |
Erickson LA, Rivera M, Zhang J. Adrenocortical carcinoma: review and update[J]. Adv Anat Pathol, 2014,21(3):151-159.
URL
|
[2] |
Fassnacht, M., Libé, R., Kroiss, M. et al. Adrenocortical carcinoma: a clinician's update[J]. Nat Rev Endocrinol, 2011,7(6), 323-335.
|
[3] |
Ribeiro RC, Figueiredo B. Childhood adrenocortical tumours[J]. Eur J Cancer, 2004, 40(8): 1117-1126.
URL
|
[4] |
Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: united states seer program 1975-1995, national cancer institute, seer program[M]. NIH, 1999,99-4649.
|
[5] |
陈琛君,郭云飞,马耿, 等. 儿童肾上腺皮质癌的诊断与预后[J].中国肿瘤临床, 2019, 46(13): 673-677.
|
[6] |
Libè R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management[J]. Endocr Relat Cancer, 2007, 14(1): 13-28
|
[7] |
Chen QL, Su Z, Li YH, et al. Clinical characteristics of adrenocortical tumors in children[J]. J Pediatr Endocr Met, 2011, 24(7-8): 535-541
URL
|
[8] |
Dackiw AP, Lee JE, Gagel RF, et al. Adrenal cortical carcinoma[J]. World J Surg, 2001, 25(7): 914-926.
URL
|
[9] |
Jasim S, Habra MA. Management of adrenocortical carcinoma[J]. Curr Oncol Rep, 2019, 21(3): 20.
|
[10] |
Arlt W, Biehl M, Taylor AE, et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors[J]. J Clin Endocrinol Metab, 2011, 96(12): 3775-3784
|
[11] |
沃方明,王玉涛,张建, 等. 肾上腺皮质癌的CT、MRI及PET/CT表现[J]. 医学影像学杂志, 2018, 28(6): 993-996,1000.
|
[12] |
Lau SK, Weiss LM. The Weiss system for evaluating adrenocortical neoplasms: 25 years later[J]. Hum Pathol, 2009, 40(6): 757-768.
URL
|
[13] |
Aubert S, Wacrenier A, Leroy X, et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors[J]. Am J Surg Pathol, 2002, 26(12): 1612-1619.
|
[14] |
Mukherjee G, Datta C, Chatterjee U, et al. Histopathological study of adrenocortical masses with special references to Weiss score, Ki-67 index and p53 status[J]. Indian J Pathol Microbiol, 2015, 58(2): 175-180.
|
[15] |
Kendrick ML, Lloyd R, Erickson L, et al. Adrenocortical carcinoma: surgical progress or status quo? [J]. Arch Surg, 2001, 136(5): 543-549.
|
[16] |
岳晓妍,王浩宇,赖亚新. 肾上腺皮质癌治疗方式研究进展[J]. 山东医药, 2018, 58(32): 111-114.
|
[17] |
Gaujoux S, Grabar S, Fassnacht M, et al. β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma[J]. Clin Cancer Res,2011, 17(2): 328-336.
|